Trhová kapitalizácia spoločnosti Acorda Therapeutics Inc
Aká je hodnota metriky Trhová kapitalizácia spoločnosti Acorda Therapeutics Inc?
Hodnota metriky Trhová kapitalizácia spoločnosti Acorda Therapeutics Inc je $12.70M
Aká je definícia metriky Trhová kapitalizácia?
Trhová kapitalizácia (Market cap) je trhová hodnota vydaných akcií obchodovanej spoločnosti a je rovná cene akcie v danom čase vynásobenej počtom kusov vydaných akcií.
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
Trhová kapitalizácia spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Acorda Therapeutics Inc
Čomu sa venuje spoločnosť Acorda Therapeutics Inc?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Firmy s metrikou trhová kapitalizácia podobnou spoločnosti Acorda Therapeutics Inc
- Hodnota metriky Trhová kapitalizácia spoločnosti Nephros je $12.69M
- Hodnota metriky Trhová kapitalizácia spoločnosti Geiger Counter je $12.70M
- Hodnota metriky Trhová kapitalizácia spoločnosti Orea Mining je $12.70M
- Hodnota metriky Trhová kapitalizácia spoločnosti Kardex AG je $12.70M
- Hodnota metriky Trhová kapitalizácia spoločnosti Blue Note Mining je $12.70M
- Hodnota metriky Trhová kapitalizácia spoločnosti B&A je $12.70M
- Hodnota metriky Trhová kapitalizácia spoločnosti Acorda Therapeutics Inc je $12.70M
- Hodnota metriky Trhová kapitalizácia spoločnosti Imperial Helium je $12.72M
- Hodnota metriky Trhová kapitalizácia spoločnosti Oliver's Real Food je $12.72M
- Hodnota metriky Trhová kapitalizácia spoločnosti REF je $12.72M
- Hodnota metriky Trhová kapitalizácia spoločnosti Fitzroy River je $12.73M
- Hodnota metriky Trhová kapitalizácia spoločnosti Chrysalis VCT Plc je $12.73M
- Hodnota metriky Trhová kapitalizácia spoločnosti Imperial Mining je $12.74M